ThinkCyte’s mission is to provide scientists and biomedical professionals with a transformational single-cell technology that accelerates biological discoveries and enable the development of novel treatments and diagnostics through the integration of advanced hardware, machine learning, and biotechnology.
$15M sweet spot round size
2016
$15M
from 3 investors over 1 rounds
ThinkCyte raised $15M on September 29, 2024
Investors: SMBC Venture Capital, Japan Green Investment Corporation for Carbon Neutrality and + 2 Other investors